ACHV
Achieve LifeยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
ACHV Profile
Achieve Life Sciences, Inc.
A late-stage clinical pharmaceutical company that develops and commercializes cytisinicline for smoking cessaton and nicotine addiction
1040 West Georgia Street, Suite 1030, Vancouver, B.C. Canada V6E 4H1
--
Achieve Life Sciences, Inc., was established in October 1991, and OncoGenex Technologies was established in May 2000. The Company is a clinical-stage pharmaceutical company dedicated to the global development and commercialization of cytisiniclines for smoking cessation and nicotine addiction. With more than 1 billion people using tobacco worldwide and more than 28 million adults smoking in the United States alone, smoking remains the leading cause of preventable disease and death, killing more than 8 million people worldwide each year. The company's primary focus is on responding to this global pandemic.
